These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32849640)

  • 1. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment.
    Zhang W; Shen Y; Huang H; Pan S; Jiang J; Chen W; Zhang T; Zhang C; Ni C
    Front Immunol; 2020; 11():1779. PubMed ID: 32849640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.
    García-Mendoza MG; Inman DR; Ponik SM; Jeffery JJ; Sheerar DS; Van Doorn RR; Keely PJ
    Breast Cancer Res; 2016 May; 18(1):49. PubMed ID: 27169366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer.
    Zhang D; Fang J; Shan J; Xu L; Wu Y; Lu B; Zhang X; Wang C; Sun P; Wang Q
    Breast Cancer Res Treat; 2024 Aug; 207(1):15-24. PubMed ID: 38914918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.
    Badr NM; Berditchevski F; Shaaban AM
    Pathobiology; 2020; 87(2):61-74. PubMed ID: 31715606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.
    Ma YF; Chen C; Li D; Liu M; Lv ZW; Ji Y; Xu J
    Oncotarget; 2017 Jan; 8(5):7614-7624. PubMed ID: 27935862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yin-yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy.
    Zhang Z; Zhu Y; Wang Z; Zhang T; Wu P; Huang J
    Cancer Lett; 2017 May; 393():1-7. PubMed ID: 28216374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.
    Tumbath S; Jiang L; Li X; Zhang T; Zahid KR; Zhao Y; Zhou H; Yin Z; Lu T; Jiang S; Chen Y; Chen X; Fu YX; Huang X
    Oncoimmunology; 2024; 13(1):2363000. PubMed ID: 38846085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.
    Zhu X; Heng Y; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
    Hum Cell; 2024 May; 37(3):714-728. PubMed ID: 38358636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
    Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.
    Garcia-Torralba E; Pérez Ramos M; Ivars Rubio A; Navarro Manzano E; Blaya Boluda N; Lloret Gil M; Aller A; de la Morena Barrio P; García Garre E; Martínez Díaz F; García Molina F; Chaves Benito A; García-Martínez E; Ayala de la Peña F
    Breast Cancer Res Treat; 2024 Jun; 205(3):475-485. PubMed ID: 38453782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Immunotherapy in Metastatic Breast Cancer.
    Mansour M; Teo ZL; Luen SJ; Loi S
    Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer.
    Hajizadeh F; Aghebati Maleki L; Alexander M; Mikhailova MV; Masjedi A; Ahmadpour M; Hashemi V; Jadidi-Niaragh F
    Life Sci; 2021 Jan; 264():118699. PubMed ID: 33137368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil plasticity in the tumor microenvironment.
    Giese MA; Hind LE; Huttenlocher A
    Blood; 2019 May; 133(20):2159-2167. PubMed ID: 30898857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment.
    Kaltenmeier C; Yazdani HO; Morder K; Geller DA; Simmons RL; Tohme S
    Front Immunol; 2021; 12():785222. PubMed ID: 34899751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
    Baxevanis CN; Fortis SP; Perez SA
    Semin Cancer Biol; 2021 Jul; 72():76-89. PubMed ID: 31881337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
    Lusho S; Durando X; Bidet Y; Molnar I; Kossai M; Bernadach M; Lacrampe N; Veyssiere H; Cavaille M; Gay-Bellile M; Radosevic-Robin N; Abrial C
    Medicine (Baltimore); 2020 Dec; 99(50):e23418. PubMed ID: 33327268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.